Clinical trial
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute…
NCT00410657 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00410657 |
|---|---|
| Title | Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant |
| Official title | A Phase II Study to Evaluate Low-Dose Alemtuzumab as a Glucocorticoid-Sparing Agent for Initial Systemic Treatment of Acute Graft-Versus-Host Disease |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Neuroblastoma and 2 more |
| Intervention type | Biological, Drug, Other |
| Interventions | alemtuzumab, methylprednisolone, prednisone, flow cytometry, immunologic technique, pharmacological study |
| Enrollment | 53 |
| Start date | Jul 1, 2006 |
| Primary completion | Nov 1, 2006 |
| First posted | Dec 13, 2006 |
| Last update posted | May 14, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: